1. Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones by Asle Charles Hesla, Panagiotis Tsagozis, Nina Jebsen, Olga Zaikova, Henrik Bauer, and Otte Brosjö J Bone Joint Surg Am Volume 98(3):199-210 February 3, 2016 ©2016 by The Journal of Bone and Joint Surgery, Inc.

2. Flowchart showing differences in local treatment for patients with Ewing sarcoma of the sacrum and patients with Ewing sarcoma of the innominate bones. Asle Charles Hesla et al. J Bone Joint Surg Am 2016;98:199-210 ©2016 by The Journal of Bone and Joint Surgery, Inc.

3. Local recurrence-free survival analysis of 110 pelvic Ewing sarcomas showing cumulative five- year local recurrence-free survival rates of 95% and 85%, respectively, for sacral and innominate bone tumors (log-rank test, p = 0.18). Asle Charles Hesla et al. J Bone Joint Surg Am 2016;98:199-210 ©2016 by The Journal of Bone and Joint Surgery, Inc.

4. Disease-free survival analysis of 117 pelvic Ewing sarcomas showing cumulative five-year disease-free survival rates of 66% and 40%, respectively, for sacral and innominate bone tumors (log-rank test, p = 0.01). Asle Charles Hesla et al. J Bone Joint Surg Am 2016;98:199-210 ©2016 by The Journal of Bone and Joint Surgery, Inc.

5. Overall survival analysis of 117 pelvic Ewing sarcomas showing cumulative five-year overall survival rates of 65% and 49%, respectively, for sacral and innominate bone tumors (log-rank test, p = 0.08). Asle Charles Hesla et al. J Bone Joint Surg Am 2016;98:199-210 ©2016 by The Journal of Bone and Joint Surgery, Inc.

6. The cumulative overall survival of patients with intralesional or marginal margin without radiation treatment compared with patients with intralesional or marginal margin with postoperative radiation treatment (log-rank test, p = 0.04). Asle Charles Hesla et al. J Bone Joint Surg Am 2016;98:199-210 ©2016 by The Journal of Bone and Joint Surgery, Inc.

7. The cumulative overall survival of patients with wide margin without radiation treatment compared with patients with intralesional or marginal margin with postoperative radiation treatment (log-rank test, p = 0.91). Asle Charles Hesla et al. J Bone Joint Surg Am 2016;98:199-210 ©2016 by The Journal of Bone and Joint Surgery, Inc.